NCT00394914View on ClinicalTrials.gov

Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295)

PHASE2CompletedINTERVENTIONAL
Enrollment

311

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
AsthmaCommon ColdPicornavirus InfectionRhinovirus
Interventions
DRUG

Pleconaril

Pleconaril nasal suspension is supplied in a bottle containing 120 actuations. Each actuation contains 1.5 mg of pleconaril.

DRUG

Placebo to Pleconaril

Placebo nasal suspension

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00394914 - Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295) | Biotech Hunter | Biotech Hunter